Oral Alpan

4.0k total citations · 3 hit papers
29 papers, 1.8k citations indexed

About

Oral Alpan is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Oral Alpan has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Oral Alpan's work include Lysosomal Storage Disorders Research (5 papers), Eosinophilic Esophagitis (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). Oral Alpan is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Eosinophilic Esophagitis (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). Oral Alpan collaborates with scholars based in United States, United Kingdom and Denmark. Oral Alpan's co-authors include Karin Rosén, Polly Matzinger, Alexandra F. Santos, Hans Jürgen Hoffmann, William W. Busse, Mark D. Eisner, Irmarie Reyes‐Rivera, Jin Zhu, John J. Condemi and Nicola A. Hanania and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Nature Immunology.

In The Last Decade

Oral Alpan

28 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

2011 429 citations Oral Alpan, Karin Rosén et al. profile →
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

2014 307 citations Sarbjit S. Saini, Carsten Bindslev‐Jensen et al. Journal of Investigative Dermatology profile →
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

2021 171 citations Oral Alpan et al. profile →

Peers

Countries citing papers authored by Oral Alpan

Since Specialization

Citations

This map shows the geographic impact of Oral Alpan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oral Alpan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oral Alpan more than expected).

Fields of papers citing papers by Oral Alpan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oral Alpan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oral Alpan. The network helps show where Oral Alpan may publish in the future.

Co-authorship network of co-authors of Oral Alpan

This figure shows the co-authorship network connecting the top 25 collaborators of Oral Alpan. A scholar is included among the top collaborators of Oral Alpan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oral Alpan. Oral Alpan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Basophil activation test; User's manual 2025 ·Journal of Immunological Methods ·Søren Ulrik Sønder, Matthew Plassmeyer, (unknown), (unknown), Mikell Paige, Michael Girgis, (unknown), Oral Alpan	1
2	Towards an FDA-cleared basophil activation test 2023 ·SHILAP Revista de lepidopterología ·Oral Alpan, Richard L. Wasserman, (unknown), Amy Darter, (unknown), Douglas H. Jones, (unknown), Henry Li, (unknown), Melinda M. Rathkopf, Elena Pérez, Dareen Siri, (unknown), Matthew Plassmeyer, (unknown), (unknown), Sean OʼReilly, Søren Ulrik Sønder, Gerald E. Marti	12
3	Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo 2022 ·The Journal of Rheumatology ·(unknown), (unknown), Madhavi Latha Somaraju Chalasani, Susan Chyou, William Shipman, Orla O’Shea, Joanna Harp, Oral Alpan, Stéphane Zuily, Theresa T. Lu, Doruk Erkan	8
4	Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies 2022 ·Frontiers in Immunology ·Thomas A. Premeaux, Stephen T. Yeung, (unknown), (unknown), Oral Alpan, Raavi Gupta, Lishomwa C. Ndhlovu	16
5	Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies 2021 ·Frontiers in Immunology ·Elena Pérez, Jacques Hébert, Anne K. Ellis, Oral Alpan, William R. Lumry, Ralph Shapiro, Daniel Suez, (unknown), Richard L. Wasserman	3
6	SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus 2021 ·Communications Biology ·Mikail Dogan, Lina Kozhaya, Lindsey Placek, (unknown), (unknown), Rachel Hardy, Matthew Plassmeyer, (unknown), (unknown), (unknown), Michael Kleinberg, Chelsea Hayes, Moshe Arditi, Ellen Klapper, Noah Merin, (unknown), Raavi Gupta, Oral Alpan, Derya Unutmaz	75
7	A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis 2018 ·Pediatric Rheumatology ·Daniel J. Lovell, Jason Dare, Megan Francis‐Sedlak, Julie Ball, Brian LaMoreaux, Emily von Scheven, Adam Reinhardt, Rita Jerath, Oral Alpan, Ramesh K. Gupta, Donald P. Goldsmith, Andrew Zeft, (unknown), Beth S. Gottlieb, Lawrence Jung, Robert J. Holt	6
8	Improved panels for clinical immune phenotyping: Utilization of the violet laser 2017 ·Cytometry Part B Clinical Cytometry ·(unknown), Matthew Plassmeyer, (unknown), (unknown), (unknown), (unknown), Raavi Gupta, Oral Alpan, Søren Ulrik Sønder	4
9	Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease 2016 ·PLoS ONE ·Renuka P. Limgala, (unknown), Matthew Plassmeyer, (unknown), Lina Kozhaya, (unknown), (unknown), Derya Unutmaz, Oral Alpan, Özlem Göker-Alpan	26
10	Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease 2016 ·Blood Cells Molecules and Diseases ·Renuka P. Limgala, (unknown), (unknown), Oral Alpan, Özlem Göker-Alpan	3
11	Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease 2016 ·Blood Cells Molecules and Diseases ·Søren Ulrik Sønder, Renuka P. Limgala, Margarita M. Ivanova, (unknown), Matthew Plassmeyer, Gerald E. Marti, Oral Alpan, Özlem Göker-Alpan	19
12	A Pilot Study of Omalizumab in Eosinophilic Esophagitis 2015 ·PLoS ONE ·(unknown), Benjamin Enav, Edina Komlódi-Pásztor, (unknown), (unknown), (unknown), (unknown), (unknown), Renuka P. Limgala, Margaret R. Brown, Raavi Gupta, (unknown), Özlem Göker-Alpan, Amer Khojah, Oral Alpan	115
13	Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study breakdown → 2014 ·Journal of Investigative Dermatology ·Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer, Jean‐Jacques Grob, Emel Bülbül Başkan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon L. Spector, Karin Rosén	307
14	Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis 2014 ·Journal of Allergy and Clinical Immunology ·Marc E. Rothenberg, Ting Wen, Allison Greenberg, Oral Alpan, Benjamin Enav, Ikuo Hirano, Kari C. Nadeau, Sérgio Kaiser, Thomas Peters, (unknown), Ieuan Jones, P. Jonathan, Robert M. Strieter, (unknown), Kulasiri A. Gunawardena	222
15	Normal B Cell Subpopulations in the Pediatric Age Groups and Adults 2013 ·Journal of Allergy and Clinical Immunology ·Matthew Plassmeyer, (unknown), Margaret R. Brown, (unknown), (unknown), Oral Alpan	0
16	Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy 2013 ·Case Reports in Gastroenterology ·Stephan Miehlke, Oral Alpan, Sören Schröder, Alex Straumann	101
17	'Educated' dendritic cells act as messengers from memory to naive T helper cells 2004 ·Nature Immunology ·Oral Alpan, Eric M. Bachelder, (unknown), Heinz Arnheiter, Polly Matzinger	111
18	The Role of Dendritic Cells, B Cells, and M Cells in Gut-Oriented Immune Responses 2001 ·The Journal of Immunology ·Oral Alpan, (unknown), Polly Matzinger	132
19	Oral tolerance and gut-oriented immune response to dietary proteins 2001 ·Current Allergy and Asthma Reports ·Oral Alpan	14
20	Anti-Candida antibody levels in psoriasis vulgaris. 1990 ·PubMed ·(unknown), (unknown), Oral Alpan	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact